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Identity 
HGNC (Hugo): WT1 
Location: 11p13 




10 exons spanning 48 kb of genomic DNA. 
Transcription 
3 kb mRNA; four alternative splice forms: +/- exon 5 
and alternative splice donor sites at exon 9. 
Protein 
Description 
Four major isoforms (429-449 aa) due to alternative 
splicing; there are eight minor isoforms resulting from 
different initiation sites (upstream CTG: 502-522 aa, 
downstream ATG: 303-323 aa). 
Expression 
Kidney, spleen, mesothelia. 
Localisation 
Nuclear staining, either diffuse or in speckles, 
depending on isoform and mutations. 
Function 







Various types of mutations, mostly affecting zinc 
fingers in exons 7-10. (WAGR syndrome, genito-
urinary (GU) anomalies, Denys-Drash-syndrome, 
Frasier syndrome; see below). 
Somatic 
Biallelic inactivation in Wilms' tumors (<15%) and 




Nephroblastoma of childhood. 
Prognosis 
Good with treatment according to NWTS or SIOP. 
Cytogenetics 
11p13 deletions/translocations can be seen in some 
cases. 
Oncogenesis 
Up to 15% of tumors show mainly biallelic inactivation 
of WT1 through deletion or mutation. 







With EWS: EWS-WT; in frame fusion of EWS exons 
1-7 and WT1 exons 8-10. 
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Denys-Drash syndrome (DDS) 
Disease 
Defined by: mesangial sclerosis with kidney failure 
(age 2 yrs), gonadal dysgenesis, risk of Wilms' tumors. 
Prognosis 
Kidney failure at age 0-5 years. 
Hybrid/Mutated gene 
Dominant negative mutations, especially missense 
mutations within the zinc fingers (aa 394 Arg -> Trp) 
but very few nonsense mutations. 
Oncogenesis 
High risk of Wilms' tumor development. 
Frasier syndrome 
Disease 
Defined by: complete gonadal dysgenesis, focal 
glomerular sclerosis, gonadoblastoma; in karyotypic 
females the syndrome may be limited to focal 
glomerular sclerosis with regular gonadal development 
and function. 
Prognosis 
Kidney failure at age 10-30 years. 
Hybrid/Mutated gene 
Heterozygous point mutations of alternative splice 
donor site in exon 9 with imbalance of WT1 isoform 
ratio. 
Oncogenesis 
Gonadoblatoma may occur within streak gonads. 
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